RecallWatchUSA

Home / Brands / Amgen

Amgen Recalls

12 recalls on record · November 13, 2013 to July 1, 2026 · Drugs

Recalls by year

13
16
17
22
25
26

Count of recall notices naming this brand, by the year the recall was announced. A quiet year is not proof of a safe year.

July 1, 2026DrugsFDA
Amgen, Inc. recalls Sensipar (cinacalcet) Tablets, 90mg, 30-count bottles, Rx Only, Distributed by: Amge, One Amgen Center Drive, Thousand O
Hazard: CGMP Deviations
July 1, 2026DrugsFDA
Amgen, Inc. recalls Corlanor (ivabradine) tablets, 7.5mg, 60-count bottles, Rx Only, Amgen Inc., Thousand Oaks, CA 92130 Made In Italy. NDC
Hazard: Presence of Foreign Substance.
July 1, 2026DrugsFDA
Amgen, Inc. recalls Sensipar (cinacalcet) Tablets, 60mg, 30-count bottles, Rx Only, Distributed by: Amge, One Amgen Center Drive, Thousand O
Hazard: CGMP Deviations
July 1, 2026DrugsFDA
Amgen, Inc. recalls Sensipar (cinacalcet) Tablets, 30mg, 30-count bottles, Rx Only, Distributed by: Amge, One Amgen Center Drive, Thousand O
Hazard: CGMP Deviations
July 1, 2026DrugsFDA
Amgen, Inc. recalls Corlanor (ivabradine) tablets, 5 mg, packaged in a) 14 tablets bottles (NDC 55513-800-99), and b) 60 tablet bottles (NDC
Hazard: Presence of Foreign Substance.
March 26, 2025DrugsFDA
Amgen, Inc. recalls Neupogen (filgrastim) For Injection, 480 mcg/1.6 mL (300 mcg/1 mL), 1.6 mL single Dose Vial, Rx Only, For Subcutaneous o
Hazard: Stability data does not support expiry: the products have the potential to be out of specification at the time of expiry of 36-months.
March 26, 2025DrugsFDA
Amgen, Inc. recalls Neupogen (filgrastim) For Injection, 300mcg/1 mL, 1 mL Single Dose Vials, Rx Only, For Subcutaneous or Intravenous Use O
Hazard: Stability data does not support expiry: the products have the potential to be out of specification at the time of expiry of 36-months.
May 18, 2022DrugsFDA
Amgen, Inc. recalls MVASI (bevacizumab-awwb), Injection, For Intravenous Infusion After Dilution, 100 mg/4 ml, Single dose vial, Rx only, Ma
Hazard: Defective container: loose crimp defect, potential loss of container integrity.
September 27, 2017DrugsFDA
Amgen, Inc. recalls Procrit (epoetin alfa), 10,000 units/mL, packaged in a) box of 6 single use 1 mL vials (NDC 59676-310-01), b) box of 25
Hazard: Presence of particulate matter: glass flakes identified as lamellae observed during a routine quality inspection.
August 23, 2017DrugsFDA
Amgen, Inc. recalls Procrit Epoetin Alfa 40,000 units/mL single use vial For Intravenouse or Subcutaneous Use Only, Rx only, Manufactured by
Hazard: Presence of particulate matter: Visible glass flakes identified as lamellae in some drug product vials.
December 28, 2016DrugsFDA
Amgen, Inc. recalls AMGEN Kyprolis (carfilzomib) for injection, 30 mg per vial, Discard unused portion, For Intravenous Administration Only
Hazard: Lack of Assurance of Sterility: Potential cracks in glass vials
November 13, 2013DrugsFDA
Amgen, Inc. recalls Prolia (denosumab) Injection, 60 mg/mL, 1 x 60 mg Single Use Prefilled Syringe per carton, Rx only, Manufactured by: Amg
Hazard: Presence of Particulate Matter: Visible cellulose fibers were observed in a small number of prefilled syringes during a routine quality examination.
Amgen Recalls | RecallWatchUSA